Assignee
ZAMBON SPA
IT210 patents
Top patents by PatentIndex Score
US4982875AJan 8, 1991
Cap, reservoir and dropper assembly for bottles
ZAMBON SPA254 citations98
US5629017AMay 13, 1997
Programmed release oral solid pharmaceutical dosage form
ZAMBON SPA134 citations96
US5196440AMar 23, 1993
Compounds active as inhibitors of the cholesterol biosynthesis
ZAMBON SPA68 citations96
US4940800AJul 10, 1990
Beazimidazole compounds active as inhibitors of the cholesterol biosynthesis
ZAMBON SPA67 citations96
US6498160B2Dec 24, 2002
Phthalazine derivatives as phosphodiesterase 4 inhibitors
ZAMBON SPA61 citations95
US6340684B1Jan 22, 2002
Phthalazine derivatives as phosphodiesterase 4 inhibitors
ZAMBON SPA47 citations95
US5567844AOct 22, 1996
Process for preparing 1-phenyl-2-amino-3-fluoro-1-propanols
ZAMBON SPA50 citations94
US5510385AApr 23, 1996
Pharmaceutical compositions containing the salts of S(+)-2-(4-isobutylphenyl)propionic acid with basic aminoacids
ZAMBON SPA74 citations94
US5510101AApr 23, 1996
Ophthalmic pharmaceutical composition containing N-acetyl-cysteine and polyvinylalcohol
ZAMBON SPA93 citations94
US5445828AAug 29, 1995
Programmed release oral solid pharmaceutical dosage form
ZAMBON SPA60 citations94
US5310558AMay 10, 1994
Programmed release oral solid pharmaceutical dosage form
ZAMBON SPA56 citations94
US4743700AMay 10, 1988
Process for fluorinating 1-phenyl-2-amino-1,3-propanediol compounds
ZAMBON SPA71 citations94
US4689218AAug 25, 1987
Effervescent composition with analgesic activity
ZAMBON SPA78 citations94
US6525055B1Feb 25, 2003
Tricyclic phthalazine derivatives as phosphodiesterase 4 inhibitors
ZAMBON SPA28 citations92
US6297257B1Oct 2, 2001
Benzazine derivatives phosphodiesterase 4 inhibitors
ZAMBON SPA34 citations92
US5739123AApr 14, 1998
Phosphinic acid derivatives with metallopeptidase inhibitory activity
ZAMBON SPA50 citations92
US5468746ANov 21, 1995
Compounds active on the cardiovascular system
ZAMBON SPA36 citations92
US5463117AOct 31, 1995
Process for the preparation of salts of 2-(4-isobutylphenyl)propionic acid
ZAMBON SPA23 citations92
US5105009AApr 14, 1992
Intermediates for the preparation of 1-(phenyl)-1-hydroxy-2-amino-3-fluoropropane derivatives
ZAMBON SPA51 citations92
US5080906AJan 14, 1992
Method and composition for oral administration of n-acetylcysteine
ZAMBON SPA23 citations92
US5081136AJan 14, 1992
1,2,3-triazole compounds active as inhibitors of the enzyme hmg-coa reductase and pharmaceutical compositions containing them
ZAMBON SPA62 citations92
US4869900ASep 26, 1989
Pharamaceutical composition containing ubidecarenone
ZAMBON SPA29 citations92
US6358973B1Mar 19, 2002
Benzazine derivatives as phosphodiesterase 4 inhibitors
ZAMBON SPA38 citations91
US6271375B1Aug 7, 2001
Ortho-metalation process for the synthesis of 2-substituted-1-(tetrazol-5-yl)benzenes
ZAMBON SPA28 citations91
US6005005ADec 21, 1999
Liquid pharmaceutical composition for oral use containing 2-(4-isobutylphenyl) propionic acid
ZAMBON SPA28 citations91
US5747513AMay 5, 1998
Derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene active on the cardiovascular system
ZAMBON SPA22 citations91
US4834966AMay 30, 1989
Pharmaceutical composition with analgesic activity
ZAMBON SPA40 citations91
US7419961B2Sep 2, 2008
9a-azalides with anti-inflammatory activity
ZAMBON SPA24 citations90
US6468979B1Oct 22, 2002
Erythromycin derivatives with antibiotic activity
ZAMBON SPA33 citations90
US5807894ASep 15, 1998
Syrup containing N-acetyl-cysteine
ZAMBON SPA22 citations89
US5767161AJun 16, 1998
Pharmaceutical compositions for topical use containing (S)-2-(4-isobutylphenyl) propinonic acid
ZAMBON SPA50 citations89
US5550287AAug 27, 1996
Process for the preparation and purification of iodinated contrast agents
ZAMBON SPA24 citations89
US5695464ADec 9, 1997
Method of injection controlled by an infusion pump
ZAMBON SPA107 citations88
US5362905ANov 8, 1994
Process for the preparation of L-5-(2-acetoxy-propionylamino)-2,4,6-triiodo-isophthalic acid dichloride
ZAMBON SPA28 citations88
US4761399AAug 2, 1988
Dipeptide compounds having pharmaceutical activity and compositions containing them
ZAMBON SPA35 citations87
US6197336B1Mar 6, 2001
Fast dissolving compositions having analgesic activity
ZAMBON SPA30 citations86
US5571941ANov 5, 1996
Process for the purifying of iopamidol
ZAMBON SPA13 citations82
US5589598ADec 31, 1996
Process of purification of 2,6-diisopropylphenol
ZAMBON SPA18 citations81
US5336664AAug 9, 1994
Compositions having herbicidal activity containing N-alkyl-amides as active ingredient
ZAMBON SPA17 citations81
US5500226AMar 19, 1996
Pharmaceutical composition having analgesic activity
ZAMBON SPA16 citations80
US4988691AJan 29, 1991
Isoxazole containing compounds exhibiting anti-serotonin activity
ZAMBON SPA21 citations80
US6589951B1Jul 8, 2003
Phthalazine derivatives as phosphodiesterase 4 inhibitors
ZAMBON SPA19 citations79
US5312627AMay 17, 1994
Transdermal therapeutic system for the administration of drugs having bronchodilating activity
ZAMBON SPA8 citations74
US5004832AApr 2, 1991
Preparing alpha-arylalkanoic acids
ZAMBON SPA9 citations74
US4983606AJan 8, 1991
Pharmaceutically-active phthalazine compounds
ZAMBON SPA10 citations74
US4937367AJun 26, 1990
Process for the preparation of intermediates for the synthesis of fosfomycin
ZAMBON SPA8 citations74
US4922009AMay 1, 1990
Stereoconvergent process for preparing optically active carboxylic acids
ZAMBON SPA6 citations74
US4734507AMar 29, 1988
Optically active ketals, processes for their preparation and their use in the synthesis of alpha-arylalkanoic acids
ZAMBON SPA5 citations74
US4697036ASep 29, 1987
Process for the preparation of optically active alpha-arylalkanoic acids and novel intermediates thereof
ZAMBON SPA11 citations74
US4501913AFeb 26, 1985
Process for preparing esters of aryl alkanoic acids
ZAMBON SPA8 citations74
Showing the top 50 of 210 patents by PatentIndex Score.